Answers are grounded in this paper and cite their sources.
• Hormone receptor-positive human epidermal growth factor receptor negative metastatic breast cancer is not curable. • Leptomeningeal breast cancer metastases, developing in 5% of patients with metastases, are usually fatal within 3–5 months. • Abemaciclib penetrates the brain and has favorable effects on the immune system and tumor microenvironment. • Early trials show abemaciclib with pembrolizumab improves symptoms in patients with leptomeningeal disease. • This combination dramatically improved symptoms in our patient who discontinued hospice and returned to work.
No takes yet. Share an insight, caveat, or question.
Mahoney et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: